| COVID-19 |
1 |
1 |
| Transplantation |
0 |
0.98 |
| Acute Respiratory Distress Syndrome |
0 |
0.8 |
| Lung Transplantation |
0 |
0.99 |
| Lung |
0 |
0.41 |
| Transplant Evaluation |
0 |
0.38 |
| Texas |
0 |
0.36 |
| Transplant Program |
0 |
0.36 |
| Severe Acute Respiratory Syndrome |
0 |
0.97 |
| Heart Failure (HF) |
0 |
0.26 |
| Bronchoalveolar Lavage |
0 |
0.15 |
| Impairment |
0 |
0.15 |
| Polymerase Chain Reaction |
0 |
0.15 |
| Pneumonia |
0 |
0.14 |
| Health Care Quality, Access, and Evaluation |
0 |
0.95 |
| Mechanical Ventilation |
0 |
0.1 |
| Pandemic |
0 |
0.96 |
| Refractory |
0 |
0.1 |
| Viral Pneumonia |
0 |
0.1 |
| CT Scan |
0 |
0.09 |
| Wound Management |
0 |
0.09 |
| Social Determinants of Health |
0 |
0.06 |
| Adherence |
0 |
0.05 |
| Airway |
0 |
0.05 |
| Anticoagulation Therapy |
0 |
0.05 |
| Biomarker |
0 |
0.05 |
| Blood |
0 |
0.05 |
| Clinical Guidelines |
0 |
0.05 |
| Coagulation |
0 |
0.05 |
| Cytokines |
0 |
0.05 |
| Extracorporeal Membrane Oxygenation (ECMO) |
0 |
0.05 |
| Graft |
0 |
0.05 |
| Injury |
0 |
0.05 |
| Inpatient Care |
0 |
0.05 |
| Intubation |
0 |
0.05 |
| Pulmonary Hypertension |
0 |
0.05 |
| Respiratory Failure |
0 |
0.05 |
| Scan |
0 |
0.05 |
| Sedative |
0 |
0.05 |
| Ventilator |
0 |
0.05 |
| Guidelines for Hypertension |
0 |
0.04 |
| Pulmonary Arterial Hypertension |
0 |
0.04 |
| Hypertension |
0 |
0.03 |
| Vaccines |
0 |
0.03 |